Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-10-08

FDA Approved: TELMISARTAN — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approves Alembic Pharmaceuticals Limited's supplemental application for telmisartan, enabling marketing of the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan (Telmisartan)

Snippet

SUPPL AP for TELMISARTAN (TELMISARTAN)